Altimmune, Inc.
NASDAQ:ALT
9.49 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.426 | -0.068 | 4.41 | 8.185 | 5.801 | 10.331 | 0.042 | 5.23 | 10.641 | 10.19 | 17.913 | 25.176 | 24.266 | 20.994 | 27.55 | 32.911 | 14.644 | 1.848 | 0.586 |
| Cost of Revenue
| 0.477 | 0.068 | 0.551 | 33.509 | 17.066 | 18.459 | 18.406 | 7.221 | 5.064 | 4.265 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.115 |
| Gross Profit
| -0.051 | -0.136 | 3.859 | -25.324 | -11.264 | -8.128 | -18.365 | -1.991 | 5.577 | 5.925 | 17.913 | 25.176 | 24.266 | 20.994 | 27.55 | 32.911 | 14.644 | 1.848 | 0.471 |
| Gross Profit Ratio
| -0.12 | 2 | 0.875 | -3.094 | -1.942 | -0.787 | -442.494 | -0.381 | 0.524 | 0.581 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.804 |
| Reseach & Development Expenses
| 65.322 | 70.538 | 74.541 | 49.774 | 17.766 | 18.459 | 18.406 | 4.836 | 5.134 | 9.32 | 15.29 | 19.51 | 21.22 | 20.876 | 30.22 | 31.812 | 16.56 | 0 | 0 |
| General & Administrative Expenses
| 18.137 | 17.134 | 15.413 | 13.209 | 8.501 | 9.766 | 8.458 | 11.515 | 6.222 | 10.912 | 13.279 | 11.629 | 14.311 | 18.016 | 22.433 | 19.398 | 13.882 | 0.491 | 0.146 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 18.137 | 17.134 | 15.413 | 13.209 | 8.501 | 9.766 | 8.458 | 11.515 | 6.222 | 10.912 | 13.279 | 11.629 | 14.311 | 18.016 | 22.433 | 19.398 | 13.882 | 0.491 | 0.146 |
| Other Expenses
| 0.166 | -0.032 | -0.374 | 0.024 | 0.015 | 0.278 | 0.006 | 0.008 | 0.008 | -0.001 | -0.006 | 0.048 | 0.461 | 5.656 | 0.872 | 0.814 | 0.705 | 0.153 | 0 |
| Operating Expenses
| 83.459 | 87.672 | 89.954 | 62.984 | 26.266 | 28.225 | 16.167 | 16.495 | 11.497 | 20.382 | 28.752 | 31.442 | 35.992 | 44.547 | 53.525 | 52.024 | 31.147 | 0.644 | 0.146 |
| Operating Income
| -83.51 | -87.74 | -96.914 | -54.799 | -21.465 | -42.834 | -52.045 | -11.264 | -3.403 | -10.191 | -10.839 | -6.266 | -11.726 | -23.554 | -25.975 | -35.244 | -16.503 | 1.203 | 0.325 |
| Operating Income Ratio
| -196.033 | 1,290.294 | -21.974 | -6.695 | -3.7 | -4.146 | -1,254.012 | -2.154 | -0.32 | -1 | -0.605 | -0.249 | -0.483 | -1.122 | -0.943 | -1.071 | -1.127 | 0.651 | 0.555 |
| Total Other Income Expenses Net
| -4.937 | 2.83 | -0.177 | 0.337 | 0.886 | -27.357 | -35.824 | 216.12 | -2.468 | 0.508 | -0.451 | 1.867 | 7.966 | -5.366 | -3.737 | -15.955 | 3.916 | 0 | 0 |
| Income Before Tax
| -88.447 | -84.91 | -97.091 | -54.462 | -20.579 | -45.321 | -52.064 | 205.024 | -3.379 | -9.894 | -11.657 | -4.725 | -3,797,573 | -34,849,277 | -32,279.76 | -36,415.113 | -13.587 | 1.203 | 0.325 |
| Income Before Tax Ratio
| -207.622 | 1,248.676 | -22.014 | -6.654 | -3.547 | -4.387 | -1,254.458 | 39.2 | -0.318 | -0.971 | -0.651 | -0.188 | -156,495.925 | -1,659,994.889 | -1,171.68 | -1,106.461 | -0.928 | 0.651 | 0.555 |
| Income Tax Expense
| 0.309 | -0.197 | -0.92 | -5.417 | -0.059 | -6.15 | -5.638 | 11.169 | 0.062 | 0.062 | 0.062 | 0.196 | -7.928 | 15.931 | 6.305 | 17.303 | -2.866 | 0.187 | 0.048 |
| Net Income
| -88.447 | -84.713 | -96.171 | -49.044 | -20.52 | -39.171 | -46.425 | 193.854 | -3.441 | -9.955 | -11.718 | -4.92 | -3.798 | -34.849 | -32.28 | -36.415 | -13.587 | 1.016 | 0.277 |
| Net Income Ratio
| -207.622 | 1,245.779 | -21.806 | -5.992 | -3.537 | -3.792 | -1,118.603 | 37.064 | -0.323 | -0.977 | -0.654 | -0.195 | -0.156 | -1.66 | -1.172 | -1.106 | -0.928 | 0.55 | 0.473 |
| EPS
| -1.66 | -1.81 | -2.33 | -1.91 | -1.56 | -13.98 | -108.77 | -49.8 | -16.13 | -51.91 | -69.4 | -30.55 | -24.07 | -323.59 | -351.19 | -476.15 | -431.69 | -11,478.11 | 12 |
| EPS Diluted
| -1.66 | -1.81 | -2.33 | -1.91 | -1.56 | -13.98 | -108.77 | -49.8 | -16.13 | -51.91 | -69.4 | -30.55 | -24.07 | -323.59 | -351.19 | -476.15 | -431.69 | -11,478.11 | 9 |
| EBITDA
| -83.033 | -84.902 | -85.715 | -54.154 | -19.219 | -17.087 | -16.072 | -227.241 | 1.753 | -10.042 | -10.654 | -5.897 | -19.231 | -12.531 | -21.365 | -2.344 | -19.714 | 1.203 | 0.325 |
| EBITDA Ratio
| -194.913 | 1,248.559 | -19.435 | -6.616 | -3.313 | -1.654 | -387.257 | -43.448 | 0.165 | -0.985 | -0.595 | -0.234 | -0.792 | -0.597 | -0.776 | -0.071 | -1.346 | 0.651 | 0.555 |